Skip to main content
. 2019 Nov 7;8(1):e1036. doi: 10.1002/mgg3.1036

Table 2.

Sequence variants detected in the SLC7A5 gene

Patient Variant Bioinformatics Databases

14,988 Hom;

9754–12388–12970 Het

c.690C > G; p.Asn230Lys

CADD: 7.151 (not deleterious)

SIFT: tolerated

PolyPhen−2: benign

Mutation Taster: disease causing

Mutation Assessor: neutral

Lost 2 ESEs

rs1060250

ExAC (G): 0.0046

gnomAD genome (G): 0.0145

gnomAD exome (G): 0.0035

NHLBI ESP (G): 0.0175

10,471 c.1123C > A; p.Pro375Thr a

CADD: 25.1 (deleterious)

SIFT: deleterious

PolyPhen−2: probably damaging

Mutation Taster: disease causing

Mutation Assessor: medium risk

No; 0/542 controls
17,410 c.816−18C > T a Abnormal quantile signal at acceptor splice site

rs754179345; 0/542 controls

ExAC (T): 1.67E−05

gnomAD genome (T): 6.47E−05

gnomAD exome (T): 1.63E−05

NHLBI ESP (G): no data

15,301 c.1290 + 44G>Aa Lost 1 ESE

rs774937771

ExAC (G): no data

gnomAD genome (G): 9.69E−05

gnomAD exome (G): 8.43E−06

NHLBI ESP (G): no data

Abbreviations: Hom, homozygous; Het, heterozygous; ESE, Exon splicing enhancer.

bold, likely pathogenic variant.

a

De novo.